PHMSCI 558 teaches basic laboratory techniques employed in pharmacological and toxicological research.
Offering recorded · Fall 2026
Recent recorded grades — Fall 2023: 4.00 GPA, 100.0% A/AB (n=25 letter grades); Fall 2024: 3.92 GPA, 100.0% A/AB (n=20 letter grades); Fall 2025: 4.00 GPA, 100.0% A/AB (n=22 letter grades). Includes jointly taught sections.
Introduction to the scientific process of drug development from discovery through clinical trials, with a focus on neurological diseases.
Offering recorded · Fall 2026
Recent recorded grades — Fall 2023: 3.97 GPA, 100.0% A/AB (n=54 letter grades); Fall 2024: 3.90 GPA, 93.5% A/AB (n=31 letter grades); Fall 2025: 3.96 GPA, 100.0% A/AB (n=51 letter grades).
CURRENT TRENDS IN DRUG DISCOVERY AND DEVELOPMENT teaches students to find, read, and critically analyze scientific and regulatory literature in drug discovery and development.
Offering recorded · Fall 2026
Recent recorded grades — Spring 2025: 3.86 GPA, 93.1% A/AB (n=29 letter grades); Fall 2025: 3.63 GPA, 89.5% A/AB (n=19 letter grades); Spring 2026: 3.85 GPA, 92.3% A/AB (n=26 letter grades).
Overview of the drug development process from discovery to investigational new drug application (IND).
Offering recorded · Fall 2026
Recent recorded grades — Fall 2024: 3.44 GPA, 67.7% A/AB (n=31 letter grades); Fall 2025: 3.39 GPA, 78.3% A/AB (n=23 letter grades); Spring 2026: 3.83 GPA, 100.0% A/AB (n=6 letter grades). Includes jointly taught sections.
PHMSCI 764 explores scientific, regulatory, and strategic considerations in modern drug development through case studies, emphasizing interdisciplinary problem-solving and emerging technologies.